IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
48 hedge funds and large institutions have $17.3M invested in IVERIC bio, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 17 reducing their positions, and 8 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less funds holding
Funds holding: 52 → 48 (-4)
18% less capital invested
Capital invested by funds: $21.2M → $17.3M (-$3.91M)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
71% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$35.6K |
| 2 |
Goldman Sachs
New York
|
+$34.2K |
| 3 |
Morgan Stanley
New York
|
+$10.1K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$6.93K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$5.52K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$335K |
| 2 |
JP Morgan Chase
New York
|
-$176K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$153K |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$109K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$98.6K |
ISEE Hedge Fund Activity: Q3 2019 in Review
48 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q3 2019, worth a combined $17.3M — down 18% from $21.2M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ISEE and 4 opened new positions — a net loss of 4 holders — while 17 trimmed existing stakes and 5 added.
The largest buyer was Vanguard Group, adding an estimated $35.6K. The largest seller was Stonepine Capital Management, cutting an estimated $335K.
- 48 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q3 2019, down from 52 in Q2 2019.
- Funds reported $17.3M of IVERIC bio, Inc. Common Stock stock for Q3 2019, down 18% quarter-over-quarter.
- 4 funds opened new IVERIC bio, Inc. Common Stock positions in Q3 2019 and 8 closed out, a net change of -4 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q3 2019 was Vanguard Group, an estimated $35.6K added.
- The largest IVERIC bio, Inc. Common Stock seller in Q3 2019 was Stonepine Capital Management, an estimated $335K sold.
Based on aggregated 13F filings for Q3 2019.